tirzepatide phase 3 The SURMOUNT-MAINTAIN 3b trial is testing if adults with obesity can maintain weight loss by continuing or reducing (vs placebo) after achieving results on the highest dose. #Tirzepatide https://t.co/FHyoDXDEYv Tirzepatide enhances weight loss with

doi: 10.1186/s12883-019-1555-4 45

If you are evaluating Ro, Orderly Meds, or other telehealth GLP-1 providers, consider asking your healthcare provider whether genetic peptide pathway testing could add value to your personalization strategy

Programs like Success by Sesame are at the forefront of this movement, combining technology, personalized medicine, and patient education to revolutionize how Americans achieve their health goals

Pharmacotherapies for post-bariatric weight regain: real-world comparative outcomes

Her body was running a calorie deficit successfully, but also running a nutrient deficit unsuccessfully

Users receive weekly check-ins and medication titration guidance coordinated with their provider